GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » COGS-to-Revenue

NuGen Medical Devices (TSXV:NGMD) COGS-to-Revenue : 0.45 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices COGS-to-Revenue?

NuGen Medical Devices's Cost of Goods Sold for the three months ended in Mar. 2024 was C$0.02 Mil. Its Revenue for the three months ended in Mar. 2024 was C$0.05 Mil.

NuGen Medical Devices's COGS to Revenue for the three months ended in Mar. 2024 was 0.45.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. NuGen Medical Devices's Gross Margin % for the three months ended in Mar. 2024 was 55.32%.


NuGen Medical Devices COGS-to-Revenue Historical Data

The historical data trend for NuGen Medical Devices's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices COGS-to-Revenue Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
0.28 0.33 0.35 0.50

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.29 0.37 0.63 0.45

NuGen Medical Devices COGS-to-Revenue Calculation

NuGen Medical Devices's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.166 / 0.331
=0.50

NuGen Medical Devices's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.021 / 0.047
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuGen Medical Devices  (TSXV:NGMD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

NuGen Medical Devices's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.021 / 0.047
=55.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


NuGen Medical Devices COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NuGen Medical Devices (TSXV:NGMD) Business Description

Traded in Other Exchanges
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Asia, Europe and others.
Executives
Richard Buzbuzian Director, Senior Officer

NuGen Medical Devices (TSXV:NGMD) Headlines

No Headlines